Related Experiment Video
Updated: Oct 14, 2025
05:27
Author Spotlight: RNA FISH for Locating lncRNA-SNHG6 in Osteosarcoma Cells
Published on: June 16, 2023
1.8K
lncRNA MELTF-AS1 facilitates osteosarcoma metastasis by modulating MMP14 expression.
Lei Ding1, Taiyuan Liu2,3, Yuan Qu4
1Department of Rehabilitation, The Second Hospital of Jilin University, Changchun 130000, Jilin, China.
Molecular Therapy. Nucleic Acids
|November 3, 2021
Summary
Long non-coding RNA MELTF-AS1 promotes osteosarcoma metastasis by upregulating MMP14. High MELTF-AS1 expression predicts poor prognosis, suggesting it as a potential therapeutic target for osteosarcoma.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Osteosarcoma is an aggressive pediatric cancer with limited treatment options for metastatic disease.
- Long non-coding RNAs (lncRNAs) are increasingly recognized for their roles in cancer development.
- Identifying novel therapeutic targets for metastatic osteosarcoma is critical.
Purpose of the Study:
- To identify abnormally expressed lncRNAs in metastatic osteosarcoma.
- To investigate the role of the upregulated lncRNA MELTF-AS1 in osteosarcoma metastasis.
- To explore the underlying molecular mechanisms of MELTF-AS1 in osteosarcoma progression.
Main Methods:
- Analysis of osteosarcoma sequencing data to identify dysregulated lncRNAs.
- Quantitative reverse transcription PCR (qRT-PCR) to assess MELTF-AS1 expression.
- In vitro (Transwell, scratch wound healing) and in vivo (lung metastasis model) assays to evaluate metastasis.
- RNA pull-down, luciferase reporter, and RNA immunoprecipitation (RIP) assays to determine molecular interactions.
Main Results:
- MELTF-AS1 was significantly upregulated in osteosarcoma tissues and cells, correlating with poor patient prognosis.
- High MELTF-AS1 expression was partly driven by transcriptional activation from RREB1.
- Knockdown of MELTF-AS1 suppressed osteosarcoma cell metastasis in vitro and in vivo.
- MELTF-AS1 interacts with miR-485-5p to regulate matrix metalloproteinase 14 (MMP14) expression.
Conclusions:
- MELTF-AS1 acts as a pro-metastasis lncRNA in osteosarcoma by enhancing MMP14 expression.
- MELTF-AS1 represents a potential diagnostic biomarker and therapeutic target for osteosarcoma.
- Targeting MELTF-AS1 may offer a novel strategy to combat osteosarcoma metastasis.
Related Concept Videos
02:39lncRNA - Long Non-coding RNAs
9.0K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.0K
02:30Metastasis
5.8K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.8K
01:22MicroRNAs
3.2K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.2K
03:03mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K